Submitted by Anonymous (not verified) on 18 October 2023 - 16:18
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Muscular Atrophy, Spinal, Date of authorisation: 18/05/2020, Revision: 13, Status: Authorised
Source: